News
While physician-scientists are supported in splitting their time between research and clinical work, nurse-scientists are not ...
For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...
Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic ...
Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...
6h
News Medical on MSNDana-Farber experts present innovative cancer studies at the 2025 AACR Annual MeetingNumerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.
Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...
Oncologists at AUA 2025 share promising data, including sasanlimab, cretostimogene grenadenorepvec, and TAR-200 in NMIBC.
Chatting with Therabot for eight weeks meaningfully reduced psychological symptoms among users with depression, anxiety or an ...
Researchers at the Pennington Biomedical Research Center have found new clues about how the drug tirzepatide, also known by ...
Psychedelic drugs, like the psilocybin found in the mushrooms, disrupt neural activity in the brain and cause cognitive and ...
As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...
6h
Stockhead on MSNHealth Check: Telix licks its wounds after FDA knocks back brain cancer diagnosticTelix Pharmaceuticals has been shocked by the US Food & Drug Administration's rejection of marketing approval for its brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results